Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Other Non Operating Income (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Other Non Operating Income for 12 consecutive years, with -$74060.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 183.31% year-over-year to -$74060.0, compared with a TTM value of $54370.0 through Dec 2025, down 59.56%, and an annual FY2025 reading of -$77546.0, down 157.68% over the prior year.
  • Other Non Operating Income was -$74060.0 for Q4 2025 at Abvc Biopharma, down from $2194.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $495312.0 in Q4 2021 and bottomed at -$77005.0 in Q2 2021.
  • Average Other Non Operating Income over 5 years is $33775.2, with a median of $3297.5 recorded in 2023.
  • The sharpest move saw Other Non Operating Income skyrocketed 62208.45% in 2022, then tumbled 14057.63% in 2023.
  • Year by year, Other Non Operating Income stood at $495312.0 in 2021, then tumbled by 108.48% to -$42014.0 in 2022, then skyrocketed by 240.45% to $59009.0 in 2023, then soared by 50.66% to $88901.0 in 2024, then tumbled by 183.31% to -$74060.0 in 2025.
  • Business Quant data shows Other Non Operating Income for ABVC at -$74060.0 in Q4 2025, $2194.0 in Q3 2025, and $136148.0 in Q2 2025.